Commerzbank Aktiengesellschaft’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-146,432
Closed -$2.89M 688
2019
Q4
$2.89M Sell
146,432
-2,058
-1% -$39.4K 0.03% 280
2019
Q3
$2.55M Sell
148,490
-146
-0.1% -$2.52K 0.02% 392
2019
Q2
$2.63M Sell
148,636
-1,912
-1% -$34.8K 0.02% 411
2019
Q1
$3.07M Buy
+150,548
New +$3.03M 0.03% 341

Other funds holding TAK

Commerzbank Aktiengesellschaft's TAK Position: Q1 2020 in Review

Commerzbank Aktiengesellschaft sold out of Takeda Pharmaceutical (TAK) in Q1 2020, closing a stake of 146,432 shares — an estimated $2.89M sold.

Commerzbank Aktiengesellschaft first reported a position in TAK in Q1 2019 and held it in 4 quarters. The position peaked at $3.07M in Q1 2019. 312 funds tracked by Wall St. Rank hold TAK as of Q1 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Takeda Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 146,432 Takeda Pharmaceutical shares in Q1 2020, an estimated $2.89M.
  • Commerzbank Aktiengesellschaft first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 4 quarters.
  • Commerzbank Aktiengesellschaft's Takeda Pharmaceutical position peaked at $3.07M in Q1 2019.
  • 312 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2020, filed 29 Apr 2020.